The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...
The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent hereditary angioedema attacks in children aged 2 to under 12, the company ...
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...
Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of cataplexy or excessive ...
VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
Pharmacy is the drug developer, overseeing clinical studies and formulation. Check the NIRF 2025 ranking of the best pharmacy ...
Dublin, Aug. 17, 2017 (GLOBE NEWSWIRE) -- The "Deuterated Drugs Formulations Therapeutics Markets Strategies" report has been added to Research and Markets' offering. Deuterated Drugs: Products, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback